Abstract
T cell receptor (TCR) stimulation results in the influx of Ca(2+), which is buffered by mitochondria and promotes adenosine triphosphate (ATP) synthesis. We found that ATP released from activated T cells through pannexin-1 hemichannels activated purinergic P2X receptors (P2XRs) to sustain mitogen-activated protein kinase (MAPK) signaling. P2XR antagonists, such as oxidized ATP (oATP), blunted MAPK activation in stimulated T cells, but did not affect the nuclear translocation of the transcription factor nuclear factor of activated T cells, thus promoting T cell anergy. In vivo administration of oATP blocked the onset of diabetes mediated by anti-islet TCR transgenic T cells and impaired the development of colitogenic T cells in inflammatory bowel disease. Thus, pharmacological inhibition of ATP release and signaling could be beneficial in treating T cell-mediated inflammatory diseases.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Active Transport, Cell Nucleus
-
Adenosine Triphosphate / analogs & derivatives
-
Adenosine Triphosphate / biosynthesis*
-
Adenosine Triphosphate / pharmacology
-
Animals
-
Autocrine Communication
-
Calcium / metabolism
-
Cell Nucleus / metabolism
-
Cell Proliferation / drug effects
-
Connexins / metabolism*
-
Cyclic AMP / metabolism*
-
Inflammation / immunology
-
Inflammation / metabolism
-
Interleukin-2 / biosynthesis
-
Lymphocyte Activation
-
MAP Kinase Signaling System / physiology
-
Mice
-
Mice, Knockout
-
Mice, Mutant Strains
-
Nerve Tissue Proteins / metabolism*
-
Purinergic P2 Receptor Antagonists
-
Receptors, Purinergic P2 / physiology*
-
Signal Transduction
-
T-Lymphocytes / immunology
-
T-Lymphocytes / physiology*
Substances
-
Connexins
-
Interleukin-2
-
Nerve Tissue Proteins
-
Panx1 protein, mouse
-
Purinergic P2 Receptor Antagonists
-
Receptors, Purinergic P2
-
2',3'-dialdehyde ATP
-
Adenosine Triphosphate
-
Cyclic AMP
-
Calcium